Home › NDC Lookup › RxCUI directory › RxCUI 1101778

Monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution [K-Phos] — RxCUI 1101778

Name: Monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution [K-Phos] (RxCUI 1101778)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1101778 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1101778

Official nameMonobasic potassium phosphate 0.0408 MEQ/ML Oral Solution [K-Phos]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asK-Phos 0.0408 MEQ/ML Oral Solution; K-Phos 500 MG Tablet for Oral Solution; Monobasic K+ phosphate 0.0408 MEQ/ML Oral Solution [K-Phos]; Monobasic Pot phosphate 0.0408 MEQ/ML Oral Solution [K-Phos]

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)2,845 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Phosphates: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question. This IV form is used when your phosphate levels are too low to safely wait for a pill to work, or when you're not able to eat or take anything by mouth right now. I...
Why am I getting this through an IV instead of just taking a phosphorus pill?
It depends on how serious your kidney issues are. If you have severe kidney disease or are on dialysis, this specific product cannot be used — your kidneys would struggle to clear...
Is it safe to get this if I have kidney problems?

📖 Read our full Potassium Phosphates guide →

🕸️ Concept Web — How Monobasic potassium phosphate 0.0408 MEQ/ML Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution [K-Phos] RxCUI 1101778 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Potassium phosphate 34322 IN
- Monobasic potassium phosphate 55019 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- K-Phos 542409 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Potassium phosphate Oral Solution 434905 SCDF
- Monobasic potassium phosphate Oral Solution 2648235 SCDFP
- Potassium phosphate Oral Liquid Product 1165727 SCDG
- Potassium phosphate Oral Product 1165728 SCDG
- Monobasic potassium phosphate Oral Liquid Product 2659589 SCDGP
- Monobasic potassium phosphate Oral Product 2661761 SCDGP
- Potassium phosphate Oral Solution [K-Phos] 1101777 SBDF
- Monobasic potassium phosphate Oral Solution [K-Phos] 2655255 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution 1101775 SCD
- Monobasic potassium phosphate 0.0408 MEQ/ML 1101774 SCDC
- Monobasic potassium phosphate 0.0408 MEQ/ML [K-Phos] 1101776 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution SCD · 1101775
Monobasic potassium phosphate 0.0408 MEQ/ML SCDC · 1101774
Potassium phosphate Oral Solution SCDF · 434905
Monobasic potassium phosphate Oral Solution SCDFP · 2648235
Potassium phosphate Oral Liquid Product SCDG · 1165727
Potassium phosphate Oral Product SCDG · 1165728
Monobasic potassium phosphate Oral Liquid Product SCDGP · 2659589
Monobasic potassium phosphate Oral Product SCDGP · 2661761

Brand-Name Concepts

Monobasic potassium phosphate 0.0408 MEQ/ML [K-Phos] SBDC · 1101776
Potassium phosphate Oral Solution [K-Phos] SBDF · 1101777
Monobasic potassium phosphate Oral Solution [K-Phos] SBDFP · 2655255
K-Phos Oral Liquid Product SBDG · 1168503
K-Phos Oral Product SBDG · 1168504
K-Phos BN · 542409

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1101778 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00486-1111-01	100 TABLET, SOLUBLE in 1 BOTTLE (0486-1111-01)	K Phos Original	Beach Products, Inc.	1977-03-29
00486-1111-05	500 TABLET, SOLUBLE in 1 BOTTLE (0486-1111-05)	K Phos Original	Beach Products, Inc.	1977-03-29

Observed labelers: Beach Products, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.5559

Range $0.5559–$0.5559 · middle 50% $0.5559–$0.5559 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.